Since this announcement the market hasn't given the Sigma Aldrich approval enough credit. For Sigma/Merck to test the product for 9 months and choose to solely distribute Dotz GQD's under Sigma's own brand name is a huge validation of the product by one of the biggest chemical/pharmaceutical companies in the world. How many other $10-20m Mkt cap companies on the ASX are doing actual deals with companies like Sigma/Merck?
One of the biggest risks was whether the Dotz GQD's are as good as they keep saying. This is a huge validation in that Sigma chose Dotz over other manufacturers. The Sigma approval may take time to build revenue but as far as validation of the product goes, Dotz has been significatly de-risked
Since this announcement the market hasn't given the Sigma...
Add DTZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.85M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $4.174K | 32.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21345 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
13.0¢ |
Change
0.000 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 13.0¢ | 13.0¢ | 13.0¢ | 17520 | ||
| Last updated 14.32pm 02/05/2024 ? | |||||
| DTZ (ASX) Chart |